Cargando…
Management of serious cardiac adverse effects of antipsychotic medications
The use of antipsychotic medications has now expanded to multiple mental health conditions beyond schizophrenia. This has increased the overall population exposure to these medications, which have been associated with both metabolic changes and adverse cardiovascular effects. QTc prolongation, torsa...
Autor principal: | Stoner, Steven C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
College of Psychiatric & Neurologic Pharmacists
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007733/ https://www.ncbi.nlm.nih.gov/pubmed/29955530 http://dx.doi.org/10.9740/mhc.2017.11.246 |
Ejemplares similares
-
Clinical pearls for the monitoring and treatment of antipsychotic induced metabolic syndrome
por: DeJongh, Beth M.
Publicado: (2021) -
Long-term use of antidepressants, mood stabilizers, and antipsychotics in pediatric patients with a focus on appropriate deprescribing
por: Stutzman, Danielle L.
Publicado: (2021) -
An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use
por: VandenBerg, Amy M.
Publicado: (2022) -
Medication management of bipolar disorder during the reproductive years
por: Kennedy, Mary Lindsey Hedgepeth
Publicado: (2018) -
Concepts for selection and utilization of psychiatric medications in pregnancy
por: Vickery, P. Brittany
Publicado: (2023)